[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100413922":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":44,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"University of Miami","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"endotoxin study group",null,"Patients scheduled for Percutaneous Nephrolithotomy (PCNL) as surgical treatment for their kidney stones will be evaluated for postoperative endotoxin levels as a risk marker for sepsis.",[13],{"name":14,"affiliation":5,"role":15},"Hemendra N Shah","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","3052433246","hns35@miami.edu",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"RECRUITING","Miami","Florida","33136","United States",{"type":29,"coordinates":30},"Point",[31,32],-80.19366,25.77427,{"lat":32,"lon":31},[35,38,41,42],{"name":36,"role":18,"phone":37,"phoneExt":10,"email":20},"Hemendra N Shah, MD","305-243-3246",{"name":10,"role":18,"phone":10,"phoneExt":39,"email":40},"shah","drhemendrashah@yahoo.co.in",{"name":36,"role":15,"phone":10,"phoneExt":10,"email":10},{"name":43,"role":15,"phone":10,"phoneExt":10,"email":10},"Robert Marcovich, MD",{"type":15,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Hemendra Shah","Associate Professor of clinical Urology","100413922",false,"NCT04669886","Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.","Inclusion Criteria:\n\n* Adults that is able to consent (≥ 18 years of age)\n* Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals\n* not currently immunosuppressed \\[White blood count (WBC) \\>= 2, not on immunosuppressive medications\\]\n\nExclusion Criteria:\n\n* unable to consent and \\\u003C 18 years of age\n* currently immunosuppressed (WBC \\\u003C 2, not on immunosuppressive medications)","ALL","18 Years",{"count":55,"type":56},150,"ESTIMATED","OBSERVATIONAL","The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.",[60,61],"Nephrolithiasis","Urosepsis",[63,64,65,66,67],"endotoxin","fever","infectious complications","endourology","percutaneous nephrolithotomy","2025-09-01",{"date":70,"type":71},"2025-09-03","ACTUAL",{"date":73,"type":71},"2023-11-01",{"date":75,"type":56},"2026-12-01",{"name":5,"class":6},1]